Cargando…
Bringing FAIRness to FDA data through visualization
Improving representation and inclusion in clinical trials for new medicinal products has been a high priority for federal agencies for over 2 decades, but data to evaluate progress have been difficult to access. In this issue of Patterns, Carmeli et al. provide a novel approach to aggregating and vi...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201289/ https://www.ncbi.nlm.nih.gov/pubmed/37223271 http://dx.doi.org/10.1016/j.patter.2023.100755 |